Literature DB >> 15265276

The relationships between atherosclerosis, heart disease, type 2 diabetes and dementia.

Claude Messier1, Nesrine Awad, Michèle Gagnon.   

Abstract

Type 2 diabetes in the elderly is associated with increased incidence of vascular disease, particularly, atherosclerosis of large blood vessels. Together with other risk factors such as dyslipidemia, atherosclerosis increases the risk for coronary heart disease and stroke. Most studies that have examined the impact of type 2 diabetes and other heart disease risk factors on cognitive functions do not provide evidence that heart disease risk factors (with the possible exception of triglycerides) further increase the likelihood of observing cognitive deficits in diabetic patients. However, none of these studies used imaging techniques to evaluate atherosclerosis or evidence of cerebrovascular disease, such as infarctions. The few studies that have included brain imaging suggest that evidence of cerebrovascular disease further increases the risk for dementia in diabetic patients. The results of longitudinal studies suggest that diabetes is an independent risk factor for cognitive decline and dementia. The pattern of neuropsychological performance observed in type 2 diabetic patients appears to be the result of multiple interacting processes developing over time. In addition to the detrimental effects of protracted impaired glucose regulation on the central nervous system, type 2 diabetes pathology also encompasses the detrimental effects of associated complications such as cerebrovascular disease, which is likely the main cause of the observed processing speed/reaction time decrements.

Entities:  

Mesh:

Year:  2004        PMID: 15265276     DOI: 10.1179/016164104225016263

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  10 in total

1.  Vascular and cognitive functions associated with cardiovascular disease in the elderly.

Authors:  Ronald A Cohen; Athena Poppas; Daniel E Forman; Karin F Hoth; Andreana P Haley; John Gunstad; Angela L Jefferson; David F Tate; Robert H Paul; Lawrence H Sweet; Mokato Ono; Beth A Jerskey; Marie Gerhard-Herman
Journal:  J Clin Exp Neuropsychol       Date:  2008-06-16       Impact factor: 2.475

Review 2.  Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes.

Authors:  Ewan C McNay; Andrew K Recknagel
Journal:  Neurobiol Learn Mem       Date:  2011-08-30       Impact factor: 2.877

Review 3.  Review of the Diabetes Heart Study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications.

Authors:  Donald W Bowden; Amanda J Cox; Barry I Freedman; Christina E Hugenschimdt; Lynne E Wagenknecht; David Herrington; Subhashish Agarwal; Thomas C Register; Joseph A Maldjian; Maggie C-Y Ng; Fang-Chi Hsu; Carl D Langefeld; Jeff D Williamson; J Jeffrey Carr
Journal:  Rev Diabet Stud       Date:  2010-11-10

4.  High-fat diet-induced diabetes couples to Alzheimer's disease through inflammation-activated C/EBPβ/AEP pathway.

Authors:  Pai Liu; Zhi-Hao Wang; Seong Su Kang; Xia Liu; Yiyuan Xia; Chi-Bun Chan; Keqiang Ye
Journal:  Mol Psychiatry       Date:  2022-05-11       Impact factor: 13.437

5.  Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.

Authors:  Eric R Braverman; Thomas J H Chen; Thomas J Prihoda; William Sonntag; Brian Meshkin; B William Downs; Julie F Mengucci; Seth H Blum; Alison Notaro; Vanessa Arcuri; Michael Varshavskiy; Kenneth Blum
Journal:  Age (Dordr)       Date:  2007-05-12

6.  Heart rate variability and plasma norepinephrine concentration in diabetic dogs at rest.

Authors:  Prapawadee Pirintr; Winai Chansaisakorn; Monkon Trisiriroj; Sarinee Kalandakanond-Thongsong; Chollada Buranakarl
Journal:  Vet Res Commun       Date:  2012-08-02       Impact factor: 2.459

7.  The attenuation effect of potassium 2-(1-hydroxypentyl)-benzoate in a mouse model of diabetes-associated cognitive decline: The protein expression in the brain.

Authors:  Wenwen Yu; Huajing Yin; Yingni Sun; Si Shi; Jiang Li; Xiaoliang Wang
Journal:  CNS Neurosci Ther       Date:  2022-04-20       Impact factor: 7.035

8.  Different associations of premorbid intelligence vs. current cognition with BMI, insulin and diabetes in the homebound elderly.

Authors:  Mkaya Mwamburi; Wei Qiao Qiu
Journal:  Integr Mol Med       Date:  2016-02-19

9.  Cognitive dysfunction in diabetic rats is prevented by pyridoxamine treatment. A multidisciplinary investigation.

Authors:  Sarah Kassab; Paul Begley; Stephanie J Church; Sanziana M Rotariu; Cleo Chevalier-Riffard; Andrew W Dowsey; Alexander M Phillips; Leo A H Zeef; Ben Grayson; Joanna C Neill; Garth J S Cooper; Richard D Unwin; Natalie J Gardiner
Journal:  Mol Metab       Date:  2019-08-05       Impact factor: 7.422

10.  Obesity and Age-Related Changes in the Brain of the Zucker Lepr fa/fa Rats.

Authors:  Daniele Tomassoni; Ilenia Martinelli; Michele Moruzzi; Maria Vittoria Micioni Di Bonaventura; Carlo Cifani; Francesco Amenta; Seyed Khosrow Tayebati
Journal:  Nutrients       Date:  2020-05-09       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.